Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03747601 · ClinicalTrials.gov registry record · NA
Temporal Interference Brain Stimulation
A NA study, sponsored by Beth Israel Deaconess Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT03747601 is a NA study that was terminated before completion, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 8 participants.
The verdict
NCT03747601, a NA study, was terminated before completion, sponsored by Beth Israel Deaconess Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
The primary aim of this study is to translate temporal interference (TI) stimulation methodology into humans and examine its safety, feasibility, steerability, and focality. In the proposed early phase human experiment, the ability to apply TI stimulation will be assessed along spatial dimensions to selectively modulate neural activity and assess the feasibility of selective targeting deep brain structures without exciting overlaying cortex. The overall goal of the study is to advance TI methodology and its translation to humans. The specific aims in this study are to * Assess the safety of TI stimulation. * Assess the feasibility, focality, and steerability of TI stimulation by selectively modulating activity in subregions of a cortical area (calcarine cortex) It is hypothesized that TI stimulation can be used to impact different regions of the visual field that are represented within the calcarine fissure of the human brain. It is hypothesized that TI will be well tolerated by human subjects and side effects will be consistent with other forms of transcranial electric current stimulation (tES).
Interventions
- DEVICE Temporal Interference (TI) Stimulation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2019-09-19 |
| Est. Completion | 2023-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03747601
The ClinicalTrials.gov registry entry for NCT03747601 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Temporal Interference (TI) Stimulation is the first listed.
NCT03747601 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03747601 about?
NCT03747601 is a clinical study titled "Temporal Interference Brain Stimulation". The primary aim of this study is to translate temporal interference (TI) stimulation methodology into humans and examine its safety, feasibility, steerability, and focality. In the proposed early phase human experiment, the ability to apply TI stimulation will be assessed along spatial dimensions to...
What is the current status of trial NCT03747601?
This trial is currently terminated. It is a NA study. The enrollment target is 8 participants. The study started on 2019-09-19. Estimated completion is 2023-06-30.
What interventions are being tested in trial NCT03747601?
The interventions under investigation include: Temporal Interference (TI) Stimulation (DEVICE).
Who is sponsoring clinical trial NCT03747601?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.